Author:
Szász A. Marcell,Majoros Attila,Rosen Philip,Srivastava Shiv,Dobi Albert,Szendrői Attila,Kulka Janina,Nyirády Péter
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Coldman AJ, Phillips N, Pickles TA (2003) Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity. Can Med Assoc J 168(1):31–35
2. Roberts RO, Bergstralh EJ, Peterson NR, Bostwick DG, Lieber MM, Jacobsen SJ (2000) Positive and negative biopsies in the pre-prostate specific antigen and prostate specific antigen eras, 1980 to 1997. J urol 163(5):1471–1475
3. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O’Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13):1310–1319. doi: 10.1056/NEJMoa0810696
4. Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13):1320–1328. doi: 10.1056/NEJMoa0810084
5. Daskivich T, Chamie K, Kwan L, Labo J, Palvolgyi R, Dash A, Greenfield S, Litwin M (2011) Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer 117(20):4805
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献